Impact of grazoprevir and elbasvir in the treatment of hepatitis C virus-infected patients with chronic kidney disease and end-stage renal disease

Fernando Pedraza, Marco Ladino, David Roth

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)112-115
Number of pages4
JournalClinical Liver Disease
Issue number5
StatePublished - May 1 2016

ASJC Scopus subject areas

  • Hepatology

Cite this